Jeffrey Sum Lung Wong

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Peritoneal Dialysis

Ejection Fraction

Patient Reported Outcomes

Advanced Non Small Cell Lung Cancer

Top Venues

Hepatology communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey Sum Lung Wong, Roland Leung, Tan-To Cheung, Thomas Yau
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Hepatology communications 7 (6) (2023)
Jeffrey Sum Lung Wong, Roland Leung, Tan-To Cheung, Thomas Yau
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Hepatology communications 7 (6) (2023)
Jeffrey Sum Lung Wong, Roland Leung, Tan-To Cheung, Thomas Yau
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Hepatology communications 7 (6) (2023)
Jeffrey Sum Lung Wong, Roland Leung, Tan-To Cheung, Thomas Yau
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Hepatology communications 7 (6) (2023)
Jeffrey Sum Lung Wong, Roland Leung, Tan-To Cheung, Thomas Yau
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Hepatology communications 7 (6) (2023)
Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang, Bryan Cho Wing Li, Roland Leung, Joanne Chiu, Ka Wing Ma, Wong Hoi She, Josephine Tsang, Chung Mau Lo, Tan To Cheung, Thomas Yau
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (2) (2022)